vs

Side-by-side financial comparison of CapsoVision, Inc (CV) and PureCycle Technologies, Inc. (PCT). Click either name above to swap in a different company.

CapsoVision, Inc is the larger business by last-quarter revenue ($3.5M vs $2.7M, roughly 1.3× PureCycle Technologies, Inc.). CapsoVision, Inc runs the higher net margin — -223.9% vs -697.1%, a 473.2% gap on every dollar of revenue. CapsoVision, Inc produced more free cash flow last quarter ($-5.7M vs $-42.0M).

CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.

PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.

CV vs PCT — Head-to-Head

Bigger by revenue
CV
CV
1.3× larger
CV
$3.5M
$2.7M
PCT
Higher net margin
CV
CV
473.2% more per $
CV
-223.9%
-697.1%
PCT
More free cash flow
CV
CV
$36.4M more FCF
CV
$-5.7M
$-42.0M
PCT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CV
CV
PCT
PCT
Revenue
$3.5M
$2.7M
Net Profit
$-7.9M
$-18.8M
Gross Margin
54.1%
Operating Margin
-226.7%
-2196.1%
Net Margin
-223.9%
-697.1%
Revenue YoY
Net Profit YoY
71.0%
EPS (diluted)
$-0.17
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CV
CV
PCT
PCT
Q4 25
$2.7M
Q3 25
$3.5M
$2.4M
Q2 25
$3.3M
$1.6M
Q1 25
$1.6M
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Net Profit
CV
CV
PCT
PCT
Q4 25
$-18.8M
Q3 25
$-7.9M
$-28.4M
Q2 25
$-4.6M
$-144.2M
Q1 25
$8.8M
Q4 24
$-64.7M
Q3 24
$-90.6M
Q2 24
$-48.2M
Q1 24
$-85.6M
Gross Margin
CV
CV
PCT
PCT
Q4 25
Q3 25
54.1%
Q2 25
54.6%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
CV
CV
PCT
PCT
Q4 25
-2196.1%
Q3 25
-226.7%
-1602.2%
Q2 25
-140.3%
-2763.5%
Q1 25
-2387.4%
Q4 24
Q3 24
Q2 24
Q1 24
Net Margin
CV
CV
PCT
PCT
Q4 25
-697.1%
Q3 25
-223.9%
-1167.5%
Q2 25
-139.5%
-8741.8%
Q1 25
559.0%
Q4 24
Q3 24
Q2 24
Q1 24
EPS (diluted)
CV
CV
PCT
PCT
Q4 25
$-0.14
Q3 25
$-0.17
$-0.31
Q2 25
$-2.02
$-0.81
Q1 25
$0.05
Q4 24
$-0.40
Q3 24
$-0.54
Q2 24
$-0.29
Q1 24
$-0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CV
CV
PCT
PCT
Cash + ST InvestmentsLiquidity on hand
$156.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.4M
$45.9M
Total Assets
$25.7M
$922.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CV
CV
PCT
PCT
Q4 25
$156.7M
Q3 25
$234.4M
Q2 25
$284.1M
Q1 25
$22.5M
Q4 24
$15.7M
Q3 24
$83.7M
Q2 24
$10.9M
Q1 24
$25.0M
Stockholders' Equity
CV
CV
PCT
PCT
Q4 25
$45.9M
Q3 25
$20.4M
$68.2M
Q2 25
$-139.0M
$98.9M
Q1 25
$238.2M
Q4 24
$180.4M
Q3 24
$241.4M
Q2 24
$291.6M
Q1 24
$336.8M
Total Assets
CV
CV
PCT
PCT
Q4 25
$922.7M
Q3 25
$25.7M
$989.1M
Q2 25
$9.5M
$1.0B
Q1 25
$787.3M
Q4 24
$798.4M
Q3 24
$788.8M
Q2 24
$719.8M
Q1 24
$734.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CV
CV
PCT
PCT
Operating Cash FlowLast quarter
$-5.7M
$-28.7M
Free Cash FlowOCF − Capex
$-5.7M
$-42.0M
FCF MarginFCF / Revenue
-160.5%
-1559.6%
Capex IntensityCapex / Revenue
0.3%
495.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-183.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CV
CV
PCT
PCT
Q4 25
$-28.7M
Q3 25
$-5.7M
$-38.5M
Q2 25
$-9.5M
$-36.7M
Q1 25
$-38.9M
Q4 24
$-31.8M
Q3 24
$-33.4M
Q2 24
$-40.4M
Q1 24
$-39.2M
Free Cash Flow
CV
CV
PCT
PCT
Q4 25
$-42.0M
Q3 25
$-5.7M
$-42.4M
Q2 25
$-9.6M
$-45.3M
Q1 25
$-53.9M
Q4 24
$-53.4M
Q3 24
$-42.6M
Q2 24
$-50.8M
Q1 24
$-53.5M
FCF Margin
CV
CV
PCT
PCT
Q4 25
-1559.6%
Q3 25
-160.5%
-1743.1%
Q2 25
-289.0%
-2747.1%
Q1 25
-3409.6%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CV
CV
PCT
PCT
Q4 25
495.1%
Q3 25
0.3%
160.3%
Q2 25
2.1%
521.5%
Q1 25
949.6%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
CV
CV
PCT
PCT
Q4 25
Q3 25
Q2 25
Q1 25
-4.40×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CV
CV

Products$2.5M71%
Other$1.0M29%

PCT
PCT

Segment breakdown not available.

Related Comparisons